Biologics: Targets and Therapy, Volume 2, Issue 1 (2008)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Biologics: Targets and Therapy, Volume 2, Issue 1 (2008)

See all volumes and issues
Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Vol 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Vol 9, 2015 Vol 8, 2014 Vol 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Vol 3, 2009 Volume 2, 2008 Vol 1, 2007
Download citations Download PDFs Download issue

Review

Review Article
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Robert C Fang & Robert D Galiano
Pages: 1-12
Published online: 07 Mar 2008
AbstractforA review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers | Full Text | References | PDF (213.3 KB)
  • 174 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano & Sagar Lonial
Pages: 13-27
Published online: 07 Mar 2008
AbstractforClinical uses of GM-CSF, a critical appraisal and update | Full Text | References | PDF (158.9 KB)
  • 71 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Abciximab: a reappraisal of its use in coronary care
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, Roberto Ferrari & Gianfranco Percoco
Pages: 29-39
Published online: 07 Mar 2008
AbstractforAbciximab: a reappraisal of its use in coronary care | Full Text | References | PDF (197 KB)
  • 32 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi & Enrica Morra
Pages: 41-52
Published online: 07 Mar 2008
AbstractforAlemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL) | Full Text | References | PDF (104.6 KB)
  • 24 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mary F Mulcahy
Pages: 53-59
Published online: 07 Mar 2008
AbstractforBevacizumab in the therapy for refractory metastatic colorectal cancer | Full Text | References | PDF (137.9 KB)
  • 29 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Bella Kaufman, Steven Stein, Michelle A Casey & Beth O Newstat
Pages: 61-65
Published online: 07 Mar 2008
AbstractforLapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer | Full Text | References | PDF (125 KB)
  • 28 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Current and future applications of the anti-IgE antibody omalizumab
Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini & Maurizio Caserini
Pages: 67-73
Published online: 07 Mar 2008
AbstractforCurrent and future applications of the anti-IgE antibody omalizumab | Full Text | References | PDF (80.5 KB)
  • 46 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki Okuda
Pages: 75-82
Published online: 07 Mar 2008
AbstractforReview of tocilizumab in the treatment of rheumatoid arthritis | Full Text | References | PDF (311.4 KB)
  • 100 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley & Andrew H Ko
Pages: 83-95
Published online: 07 Mar 2008
AbstractforErlotinib in the treatment of advanced pancreatic cancer | Full Text | References | PDF (197.9 KB)
  • 133 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Sunitinib for advanced renal cell cancer
Chris Coppin
Pages: 97-105
Published online: 07 Mar 2008
AbstractforSunitinib for advanced renal cell cancer | Full Text | References | PDF (131.4 KB)
  • 40 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie, Chien-Fu Hung, Richard Roden & T-C Wu
Pages: 107-113
Published online: 07 Dec 2022
AbstractforCervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer | Full Text | References | PDF (81.7 KB)
  • 632 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Infliximab for the treatment of plaque psoriasis
Jennifer S Gall & Robert E Kalb
Pages: 115-124
Published online: 07 Mar 2008
AbstractforInfliximab for the treatment of plaque psoriasis | Full Text | References | PDF (101 KB)
  • 55 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Review Article
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn’s disease
An interview with David A Schwartz, 13 June 2007
David A Schwartz
Pages: 125-128
Published online: 07 Dec 2022
AbstractforThe PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn’s disease | Full Text | PDF (58.9 KB)
  • 36 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Review Article
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda & Claudia Castellini
Pages: 129-141
Published online: 07 Mar 2008
AbstractforPitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase) | Full Text | References | PDF (430.5 KB)
  • 65 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon & Tamas Revesz
Pages: 143-149
Published online: 07 Dec 2022
AbstractforGarlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL | Full Text | References | PDF (5.4 MB)
  • 37 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich & Boris Nohé
Pages: 151-160
Published online: 07 Mar 2008
AbstractforActivity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells | Full Text | References | PDF (1.5 MB)
  • 57 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Brief Communication

Article
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick & Terry Diamond
Pages: 161-163
Published online: 07 Mar 2008
AbstractforThe potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia | Full Text | References | PDF (122.2 KB)
  • 67 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Explore articles